A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)
- Status
- COMPLETED
- Phase
- PHASE4
Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib
- Status
- COMPLETED
- Phase
- N/A
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program
- Status
- COMPLETED
- Phase
- N/A
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
- Status
- RECRUITING
- Phase
- N/A
A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines
- Status
- COMPLETED
- Phase
- PHASE3
A Prospective, Two-arm, Non-interventional Study of JAKAVI® (Ruxolitinib) in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- N/A
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Managed Access Programs for LEE011, Ribociclib
- Status
- AVAILABLE
- Phase
- N/A
Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab
- Status
- COMPLETED
- Phase
- N/A
Study of Efficacy and Safety of ABO809 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines
- Status
- COMPLETED
- Phase
- PHASE3
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
- Status
- TERMINATED
- Phase
- PHASE3